Evidence map›Paper›PMID 15681408›Full record

ArticleJournal of virology2005

Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells.

René Daniel, Elena Marusich, Elias Argyris, Richard Y Zhao, Anna Marie Skalka, Roger J Pomerantz

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Possible Beneficial Actions of Caffeine in SARS-CoV-2.International journal of molecular sciences · 2021
    Review
  6. Review
  7. Article
  8. Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2017
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

René DanielThomas Jefferson University, Division of Infectious Diseases and Environmental Medicine, Department of Medicine, JAH Suite 321, 1020 Locust St., Philadelphia, PA 19107, USA. Rene.Daniel@jefferson.edu
Elena Marusich
Elias Argyris
Richard Y Zhao
Anna Marie Skalka
Roger J Pomerantz
Thomas Jefferson University · USFox Chase Cancer Center · USNorthwestern University · US

Funding

SCID HU MODEL FOR HIV INFECTION OF THE CNSP01NS027405 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI GONZALEZ-SCARANO, FRANCISCO · 1989 to 2007
$8.2M
INTEGRATION OF RETROVIRAL DNA--ACCESSING HOST TARGET DNAR01CA071515 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KATZ, RICHARD ALAN · 1996 to 2016
$7.6M
Molecular and Cellular Biology of HIV EncephalopathyP50NS027405 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI GONZALEZ-SCARANO, FRANCISCO · 2008 to 2009
$2.2M
Effects of HIV -1 Proteins on the Blood/ Brain BarrierR01NS041864 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI POMERANTZ, ROGER J · 2000 to 2004
$1.7M
MOLECULAR MECHANISMS OF HIV1 TRANSMISSION DURING HAARTR01AI046289 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI POMERANTZ, ROGER J · 1999 to 2002
$1.3M
Cellular Response to Retroviral DNA IntegrationK01CA098090 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL, RENE · 2003 to 2007
$730k
NCI NIH HHS CA71515NCI NIH HHS CA98090NCI NIH HHS K01 CA098090NCI NIH HHS R01 CA071515NIAID NIH HHS AI46289NINDS NIH HHS NS27405NINDS NIH HHS NS41864NINDS NIH HHS P01 NS027405NINDS NIH HHS R01 NS041864
6 · The paper itself

Abstract

Caffeine is an efficient inhibitor of DNA repair and DNA damage-activated checkpoints. We have shown recently that caffeine inhibits retroviral transduction of dividing cells, most likely by blocking postintegration repair. This effect may be mediated at least in part by a cellular target of caffeine, the ataxia telangiectasia-mutated and Rad3-related (ATR) kinase. In this study, we present evidence that caffeine also inhibits efficient transduction of nondividing cells. We observed reduced transduction in caffeine-treated growth-arrested cells as well as caffeine-treated terminally differentiated human neurons and macrophages. Furthermore, this deficiency was observed with a human immunodeficiency virus type 1 (HIV-1) vector lacking Vpr, indicating that the effect is independent of the presence of this viral protein in the infecting virion. Finally, we show that HIV-1 transduction of nocodazole-arrested cells is reduced in cells that express an ATR dominant-negative protein (kinase-dead ATR [ATRkd]) and that the residual transduction of ATRkd-expressing cells is relatively resistant to caffeine. Taken together, these data suggest that the effect(s) of caffeine on HIV-1 transduction is mediated at least partly by the inhibition of the ATR pathway but is not dependent on the caffeine-mediated inhibition of cell cycle checkpoints.

Indexed as

Transduction, GeneticCaffeineCell Cycle ProteinsCell LineGenetic VectorsHIV-1HumansVirus IntegrationCaffeineCell Cycle Proteins

Identifiers

PMID15681408
PMCPMC546572
OpenAlexW2096344288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.